Lynne Hughes is vice president and head of Quintiles’ Neurology Center of Excellence, where she develops evidence-based strategies to conduct clinical programs for customers. She also leads the Autism Center of Excellence, which provides therapeutic input and expertise for conducting trials in patients with autism spectrum disorders to improve their neurocognitive function.
A biopharmaceutical industry veteran, Dr. Hughes has worked in the industry for nearly 30 years, including 19 years at Quintiles. She possesses expertise in all areas of neurology, including Alzheimer’s disease, multiple sclerosis, Parkinson’s disease, epilepsy, acute care and pain. Dr. Hughes has been involved in the clinical trial development of many of the neurological therapies on the market today.
Dr. Hughes earned her bachelor’s degree in Medical Sciences from the University of Bradford in Bradford, England. She completed her Ph.D. in Oncology and Cancer Biology at the University of Birmingham, in Birmingham, England, fully sponsored by Cancer Research UK. In addition, she is certified as a Project Management Professional.